Unum Therapeutics Inc (NASDAQ:UMRX)

0.9493
Delayed Data
As of Jan 17
 -0.0157 / -1.63%
Today’s Change
0.48
Today|||52-Week Range
4.87
+31.81%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Unum Therapeutics Inc have a median target of 7.00, with a high estimate of 18.00 and a low estimate of 3.00. The median estimate represents a +637.39% increase from the last price of 0.95.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Unum Therapeutics Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.30
Sales
$4.1M
Reporting Date
Mar 26

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 23.08%
 
 
 
 
 
 
Growthannually 0.48%
 
 
 
 

Sales

Growthquarterly 303.53%
 
 
 
 
 
 
Growthannually 11.82%
 
 
 
 
Key to the earnings and sales forecast charts.